Smartphone-Based Self-Assessment of Objective Functional Impairment (6-Minute Walking Test) in Patients Undergoing Epidural Steroid Injection

다국어 초록 (Multilingual Abstract)

Epidural steroid injection (ESI) represents a popular treatment option in patients with lumbar degenerative disc disease (DDD). The main objective of the article was to determine whether the 6-minute walking test (6WT) could assist in the discrimination between ESI responders and nonresponders. We used a validated 6WT smartphone application to assess self-measured objective functional impairment (OFI) in 3 patients with DDD undergoing ESI. Patient-reported outcome measures (PROMs), including the Core Outcome Measures Index and the Oswestry Disability Index, were obtained at baseline and at the 3-, 7-, and 28-day follow-up. Descriptive analyses were used to compare PROMs with OFI over time. Two patients responded well to the ESI, illustrated by clinically meaningful improvements in PROMs. This improvement was accompanied by a substantial increase in the 6WT distance (case I: 358 m vs. 517 m and case II: 296 m vs. 625 m). One patient reported only moderate improvement in leg pain and conflicting results in the other PROMs. The 6WT demonstrated a persistent OFI (487 m vs. 488 m). This patient was considered a nonresponder and underwent surgical treatment. This case series illustrates the feasibility of the smartphone-based 6WT as a tool to assess OFI in patients undergoing ESI for lumbar DDD.

참고문헌 (Reference)

1 Vad VB, "Transforaminal epidural steroid injections in lumbosacral radiculopathy: a prospective randomized study" 27 : 11-16, 2002

2 Joswig H, "The value of short-term pain relief in predicting the long-term outcome of lumbar transforaminal epidural steroid injections" 107 : 764-771, 2017

3 Mannion AF, "The quality of spine surgery from the patient’s perspective. Part 1 : the Core Outcome Measures Index in clinical practice" 18 (18): 367-373, 2009

4 Fairbank JC, "The Oswestry low back pain disability questionnaire" 66 : 271-273, 1980

5 Falvo MJ, "Six-minute walk distance in persons with Parkinson disease : a hierarchical regression model" 90 : 1004-1008, 2009

6 Martin N. Stienen, "Reliability of the 6-minute walking test smartphone application" Journal of Neurosurgery Publishing Group (JNSPG) 31 (31): 786-793, 2019

7 Karppinen J, "Periradicular infiltration for sciatica: a randomized controlled trial" 26 : 1059-1067, 2001

8 Navabi N, "Older adults’ attitudes and barriers toward the use of mobile phones" 11 : 1371-1378, 2016

9 Stienen MN, "Objective measures of functional impairment for degenerative diseases of the lumbar spine : a systematic review of the literature" 19 : 1276-1293, 2019

10 Yuksel S, "Minimum clinically important difference of the health-related quality of life scales in adult spinal deformity calculated by latent class analysis:is it appropriate to use the same values for surgical and nonsurgical patients?" 19 : 71-78, 2019

11 Bennell K, "Measures of physical performance assessments: Self-Paced Walk Test (SPWT), Stair Climb Test (SCT), Six-Minute Walk Test (6MWT), Chair Stand Test (CST), Timed Up & Go (TUG), Sock Test, Lift and Carry Test (LCT), and Car Task" 63 (63): S350-S370, 2011

12 Perera S, "Meaningful change and responsiveness in common physical performance measures in older adults" 54 : 743-749, 2006

13 Redelmeier DA, "Interpreting small differences in functional status : the Six Minute Walk test in chronic lung disease patients" 155 : 1278-1282, 1997

14 Lipsmeier F, "Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson’s disease clinical trial" 33 : 1287-1297, 2018

15 Carette S, "Epidural corticosteroid injections for sciatica due to herniated nucleus pulposus" 336 : 1634-1640, 1997

16 Kehmeier ES, "Diagnostic value of the six-minute walk test(6MWT)in grown-up congenital heart disease(GUCH) : Comparison with clinical status and functional exercise capacity" 203 : 90-97, 2016

17 Berry JD, "Design and results of a smartphone-based digital phenotyping study to quantify ALS progression" 6 : 873-881, 2019

18 Asher AL, "Defining the minimum clinically important difference for grade I degenerative lumbar spondylolisthesis : insights from the Quality Outcomes Database" 44 : E2-, 2018

19 Tomkins CC, "A criterion measure of walking capacity in lumbar spinal stenosis and its comparison with a treadmill protocol" 34 : 2444-2449, 2009

20 Witherspoon JW, "6-minute walk test as a measure of disease progression and fatigability in a cohort of individuals with RYR1-related myopathies" 13 : 105-, 2018